Bioequivalence Study of Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS ® 250/50 Inhalation Powder/GSK in Healthy Volunteers

Conditions:   Bioequivalence;   Asthma Interventions:   Drug: Test;   Drug: Reference Sponsors:   Respirent Pharmaceuticals Co Ltd.;   Becro Ltd. Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials